Your browser doesn't support javascript.
loading
Outcomes following radiation for cutaneous squamous cell carcinoma of the head and neck: Associations between immune suppression and recurrence.
Arbab, Mona; Margalit, Danielle N; Tishler, Roy B; Rabinowits, Guilherme; Pashtan, Itai M; Borgelt, Bruce B; Powlis, William; Holdsworth, Clay H; Warren, Laura E; Schoenfeld, Jonathan D.
Afiliação
  • Arbab M; Department of Radiation Oncology, Dana-Farber/ Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Margalit DN; Department of Radiation Oncology, Dana-Farber/ Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Tishler RB; Department of Radiation Oncology, Dana-Farber/ Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Rabinowits G; Medical Oncology Department, Miami Cancer Institute, Miami, Florida.
  • Pashtan IM; Department of Radiation Oncology, Dana-Farber/ Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Borgelt BB; Department of Radiation Oncology, Dana-Farber/ Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Powlis W; Department of Radiation Oncology, Dana-Farber/ Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Holdsworth CH; Department of Radiation Oncology, Dana-Farber/ Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Warren LE; Department of Radiation Oncology, Dana-Farber/ Brigham and Women's Cancer Center, Boston, Massachusetts.
  • Schoenfeld JD; Department of Radiation Oncology, Dana-Farber/ Brigham and Women's Cancer Center, Boston, Massachusetts.
Head Neck ; 41(7): 2111-2115, 2019 07.
Article em En | MEDLINE | ID: mdl-30697925
ABSTRACT

BACKGROUND:

Data evaluating outcomes and patterns of recurrence following radiation therapy (RT) for cutaneous squamous cell carcinoma (cSCC) of the head and neck are limited.

METHODS:

We performed a retrospective analysis of 111 head and neck cSCC patients treated with RT at 4 affiliated institutions.

RESULTS:

With median follow-up of 7 months, there were 29 (26%) recurrences, 73% of which were nodal (n = 21). Immunosuppression (IS) was the only factor associated with recurrence (47% in IS, 22% in non-IS, P = .04), and also with time to recurrence in multivariate analysis (HR 5.5; P = .03). No factors were associated with recurrence among patients who received definitive RT. The majority of patients who recurred were salvaged with surgery (n = 20, 69%).

CONCLUSION:

In a cohort of cSCC treated with radiotherapy, there was an association between IS and increased failure risk. The majority of failures were salvaged surgically.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas / Hospedeiro Imunocomprometido / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Head Neck Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Carcinoma de Células Escamosas / Hospedeiro Imunocomprometido / Recidiva Local de Neoplasia Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Head Neck Ano de publicação: 2019 Tipo de documento: Article